Evaxion Biotech: Funding Needed to Continue Operating

By Ben Glickman Evaxion Biotech said Friday that it needs additional funding to keep the business running into 2024. The Danish clinical-stage biotechnology...

Related Keywords

Denmark ,Danish ,Ben Glickman ,Negma Group ,Article Normal ,Biotechnology Services ,Healthcare Life Sciences ,Biology ,Biotechnology ,Political General News ,Sciences Humanities ,Synd ,Evaxion Biotech ,Devax ,Political ,General News ,Sciences ,Humanities ,Healthcare ,Life Sciences ,